No NFO data available for this page.

3 Year return

18.23%
20222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Launched on January 2013 (12 years)

Investment Details

₹500

Minimum SIP Amount

₹5000

Minimum one time investment

Fund has no lock-in period

Calculate Returns

Based on past performance of this fund

ENTER AMOUNT

Your Investment ₹18,000
Gain
  • 33.81%
  • ₹6,086
  • Total Value
  • ₹24,086

Risk Involved

scale

Your principal will be at

Very High Risk

Scheme Information

Asset Under Management

₹5487.53 Cr.

Expense Ratio

1.32% (inclusive of GST)

Exit Load

Redemption / Switch out within 12 months from the dats of allotment - i) upto 10% of the allotted Units - NIL ii) beyond 10% of the allotted Units - 1.00% Redemption / Switch out after 12 months from the date of allotment - NIL

Ratings

ARQ Rating
4.5

Ratings by other agencies

3
3
3

Tax Implications

Withdrawal within 1 year

Exit load + 15% tax on gains

Withdrawal after 1 year

10% tax on gains over ₹1 Lakh per financial year

Fund Holdings

Holdings
₹5487.53Crores
Other Holdings% of Asset
Infosys3.04 %
Larsen & Toubro2.65 %
M & M2.44 %
GSEC20362.31 %
GSEC20342.27 %
Axis Bank2.17 %
Net CA & Others2.1 %
IndusInd Bank1.82 %
GAIL (India)1.73 %
Interglobe Aviat1.7 %
GSEC20331.58 %
Bharti Airtel1.56 %
Tata Motors-DVR1.48 %
HCL Technologies1.42 %
GSEC20531.37 %
Aditya Birla Cap1.2 %
Hindalco Inds.1.19 %
Bajaj Auto1.11 %
Phoenix Mills1.09 %
GE Shipping Co0.98 %
Aurobindo Pharma0.98 %
Raymond0.93 %
Nippon Life Ind.0.92 %
REC Ltd0.92 %
HDFC Bank0.92 %
Kerala 20340.91 %
REC Ltd0.9 %
Oracle Fin.Serv.0.88 %
Oil India0.85 %
Apollo Tyres0.84 %
G R Infraproject0.8 %
Power Grid Corpn0.78 %
Shriram Finance0.77 %
Vedanta0.76 %
Marksans Pharma0.75 %
Emami0.75 %
Canara Bank0.73 %
Ajanta Pharma0.73 %
Max Financial0.71 %
Indus Towers0.71 %
Federal Bank0.7 %
Coromandel Inter0.69 %
Cipla0.67 %
Gland Pharma0.65 %
Dalmia BharatLtd0.65 %
GHCL0.65 %
Zydus Lifesci.0.62 %
Crompton Gr. Con0.58 %
Indian Bank0.58 %
Mahindra Holiday0.56 %
Glenmark Pharma.0.56 %
Fortis Health.0.55 %
Shriram Finance0.55 %
Indo Count Inds.0.53 %
Sundaram Finance0.53 %
Jindal Stain.0.51 %
S P Apparels0.5 %
Caplin Point Lab0.5 %
Star Health Insu0.49 %
Bharti Airtel PP0.49 %
Indraprastha Gas0.48 %
NIIT Learning0.47 %
Jamnagar Utiliti0.46 %
I R F C0.46 %
HDFC Bank0.46 %
Power Fin.Corpn.0.46 %
Power Fin.Corpn.0.46 %
S I D B I0.46 %
Andhra Pradesh 20360.46 %
Union Bank (I)0.45 %
NABFID0.45 %
N A B A R D0.45 %
HDB FINANC SER0.45 %
LIC Housing Fin.0.45 %
I R F C0.45 %
TMF Holdings0.45 %
Escorts Kubota0.42 %
JK Paper0.36 %
Rajasthan 20390.35 %
Bharti Hexacom0.2 %
St Bk of India0.18 %
Piramal Capital0.15 %
Uttar Pradesh 20400.14 %
TBILL-364D0.12 %
Maharashtra 20390.1 %
Gsec20390.09 %
Tamil Nadu 20270.09 %
C C I0.08 %
Uttar Pradesh 20390.05 %
Maharashtra 20280.04 %
Power Fin.Corpn.0.02 %
RAJASTHAN 20260.02 %
Life Insurance0.01 %
GSEC20270.01 %
Maharashtra 20270.01 %
Yes Bank0 %

UTI Mutual Fund Managers

VS

V Srivatsa

Fund Manager since Dec 2014

View Details

Fund House Details

UTI Mutual Fund

UTI Mutual Fund Asset management company

AUM ₹290,993.03 Cr.
No. of Schemes 250
Setup Date January 2003

Peer Comparison

Comparison with other similar funds

Schemes by UTI Mutual Fund

List of mutual fund schemes by AMC

Funds 3 Years Returns
18.24%
scheme logo

Hybrid . Aggressive Hybrid Fund

UTI Aggressive Hybrid Fund Direct Plan Growth

18.23%
6.16%

About UTI Hybrid Equity Fund Direct Plan IDCW Reinvestment

The UTI Hybrid Equity Fund is an open-ended hybrid fund offered by UTI Hybrid Equity Fund. It is categorised as a hybrid fund. The fund has an aggressive investment approach and allocates assets to a mix of equity and debt securities. Both dividends and capital gains are reinvested in the fund, giving a further boost to the scheme’s overall returns.

Investment Objectives of the Scheme

The fund's investment objective is to provide a balanced portfolio that offers both growth and income potential. The fund will achieve its objective by investing in a diversified portfolio of equity and debt securities.

Key Features of The Fund

5-year return 16.53%
Expense Ratio 1.32%
Fund Manager V Srivatsa
Fund Size ₹5487.53 Cr
Risk Profile Very High

Is This Scheme Right for Me?

The UTI Hybrid Equity Fund is a good option for investors who are looking for a balanced investment that offers both growth and income potential. The fund is also a good option for investors who are looking for an investment that can help them to achieve their financial goals over the long term. Note that investors should have a moderate risk appetite. The fund is also a good option for investors who are already invested in other equity and debt funds and are looking for a way to balance their portfolio.

AMC Contact Details

Name UTI Mutual Fund
Launch Date January 2003
Addresss First Floor, Unit No. 2, Block ‘B’, JVPD Scheme, Gulmohar Cross Road No. 9, Andheri (West), Mumbai – 400049.
Contact 1800 266 1230(+91) 022 6227 8000022 – 68990800
Email service@uti.co.in
Website https://www.utimf.com/

Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.

Plan Your Investments Efficiently

SIPs can help you invest with minimum contributions over a period of time. With Angel One's free SIP calculator online, you can set your end goal and determine the required contribution amount. Check how over time, with small contributions, you can build up enough to achieve your financial goals.

FAQs

What is today's NAV of UTI Aggressive Hybrid Fund Direct Plan IDCW Reinvestment?

NAV, or Net Asset Value, is the price of a single unit of a mutual fund. It is calculated by dividing the current value of holdings held by the mutual fund scheme at the end of the day by the total number of units issued. The NAV changes every day. The NAV of UTI Aggressive Hybrid Fund Direct Plan IDCW Reinvestment on May 29 2024, is ₹45.6259